1-11 of 11
A. Burhan Ferhanoglu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group

Maria Carmen Martinez Munoz, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Herve Ghesquieres, Luc-Matthieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, A. Burhan Ferhanoglu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso De Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda Balari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2024-205007
Published: 2024
Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5173.
https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173
Published: 2017
Journal Articles

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Anas Younes, MD, Joshua Brody, MD, Cecilia Carpio, MD, Armando Lopez-Guillermo, Dina Ben-Yehuda, MD, A. Burhan Ferhanoglu, MD, Arnon Nagler, MD, Muhit Ozcan, MD, Irit Avivi, MD, Francesc Bosch Albareda, MD PhD, María Dolores Caballero Barrigón, MD PhD, Aisha Masood, MD, Michael Streit, MD MBA, John Alvarez, MD PhD, Rob Ceulemans, MS, Behzad Kharabi Masouleh, MD, Sriram Balasubramanian, PhD, Michael Schaffer, PhD, Shean-Sheng Wang, PhD, Nele Fourneau, MD, Wojciech Jurczak, PhDMD
Journal: Blood
Blood (2017) 130 (Supplement 1): 833.
https://doi.org/10.1182/blood.V130.Suppl_1.833.833
Published: 2017
Journal Articles

The Comparison of the Autologous Peripheral Blood Stem Cell Mobilization and Collection in Young and Elderly Patients

Ayse Birekul, Ali Unal, Cagri mehmet Unal, Yildizhan Esra, Serdar Sivgin, MD, Turak Esra, Leylagul Kaynar, MD, Bulent Eser, Mustafa Cetin, MD, A. Burhan Ferhanoglu, MD
Journal: Blood
Blood (2015) 126 (23): 4747.
https://doi.org/10.1182/blood.V126.23.4747.4747
Published: 2015
Journal Articles

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Eda Tanrikulu Simsek, MD, Ahmet Emre Eskazan, MD, Mahir Cengiz, MD, M. Cem Ar, MD PhD, Seda Ekizoglu, PhD, Ayse Salihoglu, MD, Emine Gulturk, MD, Tugrul Elverdi, MD, Seniz Ongoren Aydin, MD, Ahu Senem Demiroz, MD, Ayse Nur Buyru, MD, Zafer Baslar, MD, Ugur Ozbek, MD PhD, A. Burhan Ferhanoglu, MD, Yildiz Aydin, MD, Nukhet Tuzuner, MD Professor, Teoman Soysal, MD
Journal: Blood
Blood (2015) 126 (23): 2783.
https://doi.org/10.1182/blood.V126.23.2783.2783
Published: 2015
Journal Articles

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Yucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, Tugrul Elverdi, MD, Sinem Firtina, Suzin Catal Tatonyan, Seniz Ongoren Aydin, Muhlis Cem Ar, Zafer Baslar, Muge Sayitoglu, PhD, A. Burhan Ferhanoglu, Yildiz Aydin, Ugur Ozbek, Teoman Soysal
Journal: Blood
Blood (2013) 122 (21): 384.
https://doi.org/10.1182/blood.V122.21.384.384
Published: 2013
Journal Articles

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Suzan Alp, Ayse Salihoglu, Ahmet Emre Eskazan, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, Ayse Nur Buyru, Ugur Ozbek, A. Burhan Ferhanoglu, Yildiz Aydin, Teoman Soysal
Journal: Blood
Blood (2011) 118 (21): 4429.
https://doi.org/10.1182/blood.V118.21.4429.4429
Published: 2011
Journal Articles

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Murat Ozbalak, M. Cem Ar, Ayse Salihoglu, Emine Gulturk, Ahmet Emre Eskazan, Hematologist, Seniz Ongoren Aydin, Zafer Baslar, Professor Doctor, Teoman Soysal, Professor Doctor, Yildiz Aydin, Professor Doctor, Nukhet Tuzuner, Professor Doctor, A. Burhan Ferhanoglu, Professor Doctor
Journal: Blood
Blood (2011) 118 (21): 5223.
https://doi.org/10.1182/blood.V118.21.5223.5223
Published: 2011
Journal Articles

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Ahmet Emre Eskazan, Suzin Catal Tatonyan, Ayse Salihoglu, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, A. Burhan Ferhanoglu, Nukhet Tuzuner, Yildiz Aydin, Ugur Ozbek, Teoman Soysal
Journal: Blood
Blood (2011) 118 (21): 1692.
https://doi.org/10.1182/blood.V118.21.1692.1692
Published: 2011
Journal Articles

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

Mustafa Sevinc, Ahmet Emre Eskazan, Aydin Karabulut, Msc, Suzin Catal Tatonyan, Emine Gulturk, Ayse Salihoglu, Seniz Ongoren Aydin, M. Cem Ar, Zafer Baslar, A. Burhan Ferhanoglu, Nukhet Tuzuner, Yildiz Aydin, Ugur Ozbek, Teoman Soysal
Journal: Blood
Blood (2011) 118 (21): 4603.
https://doi.org/10.1182/blood.V118.21.4603.4603
Published: 2011
Journal Articles

An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis

Kirit M Ardeshna, MD, Wendi Qian, Paul Smith, June Warden, Lindsay Stevens, Christopher FE Pocock, MD, PhD, Fiona Miall, MD, David Cunningham, MD, John Davies, MD, Jan Walewski, A. Burhan Ferhanoglu, MD, Ken Bradstock, MB, PhD, David C Linch, MD, FMedSci
Journal: Blood
Blood (2010) 116 (21): 6.
https://doi.org/10.1182/blood.V116.21.6.6
Published: 2010